The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This resource chronologically lists and briefly describes key actions taken by the Trump Administration through the Department of Health and Human Services (HHS) that affect public health in the U.S. The actions are listed in the order in which they were first issued, reported or announced.
This KFF Health Tracking Poll finds that many, including women of reproductive age, remain unfamiliar with key facts about mifepristone. Fewer than half of all adults say they believe abortion pills are safe now, compared to over half of all adults two years ago. This poll explores awareness and perception of the recent FDA review of the medication, and support for policies aimed at restricting it.
When federal health officials frame unverified [Vaccine Adverse Event Reporting System] reports as evidence of vaccine-caused deaths, it may become more difficult for health communicators to explain the system’s limitations and the vaccines’ extensive safety evidence.
These findings from the KFF/Washington Post Survey of Parents shed light on parents who support the Make America Healthy Again movement, including the issues they see as top concerns for their children's wellbeing and their attitudes when it comes to vaccines and government regulations on food.
This issue brief gives an overview of the main systems used by the federal government to track vaccine safety and adverse events following vaccinations. The brief reviews the history of federal vaccine safety systems, describes the key systems and their strengths and limitations, and also discusses how vaccine safety issues have become the subject of more scrutiny under the Trump administration.
This brief provides an overview of vaccine coverage requirements by payer or program, as they relate to ACIP and the CDC.
This brief describes four key federal vaccine advisory committees and discusses policy issues and questions they currently face. The four committees are the Vaccines and Related Biological Products Advisory Committee (VRBPAC) at the Food and Drug Administration (FDA); the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC); the National Vaccine Advisory Committee (NVAC) at the Department of Health and Human Services (HHS); and the Advisory Commission on Childhood Vaccines (ACCV) at HHS.
Taken together, the new guidance on clinical trial requirements, the more restricted approval of the Novavax vaccine, and anticipated changes to CDC recommendations add up to fewer Americans eligible for COVID-19 vaccines and more limited access to these vaccines compared to previous years...such a shift would place the U.S. more in line with Australia, Canada, and countries in Europe.
This volume examines the impact of recent executive actions on federal health communication, along with concerns and stigmas surrounding ADHD diagnoses and treatments, including skepticism about pharmaceutical influence on medication promotion. It also explores distrust in food regulations following the FDA’s ban on Red Dye No. 3.
This volume addresses rising distrust in food safety, shifts in social media content moderation, and the trend of self-diagnosis and treatment based on social media videos.
© 2025 KFF